UBS Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,562
Closed -$1.09K 8958
2023
Q4
$1.09K Buy
1,562
+1,370
+714% +$959 ﹤0.01% 7189
2023
Q3
$132 Sell
192
-94
-33% -$65 ﹤0.01% 7672
2023
Q2
$689 Sell
286
-1,545
-84% -$3.72K ﹤0.01% 7047
2023
Q1
$14.9K Buy
1,831
+1,246
+213% +$10.1K ﹤0.01% 6224
2022
Q4
$6.96K Buy
+585
New +$6.96K ﹤0.01% 7765
2022
Q3
Sell
-1,228
Closed -$43K 9991
2022
Q2
$43K Buy
1,228
+276
+29% +$9.66K ﹤0.01% 5034
2022
Q1
$39K Sell
952
-1,124
-54% -$46K ﹤0.01% 5718
2021
Q4
$89K Buy
2,076
+1,362
+191% +$58.4K ﹤0.01% 5345
2021
Q3
$49K Sell
714
-139
-16% -$9.54K ﹤0.01% 5259
2021
Q2
$66K Buy
853
+139
+19% +$10.8K ﹤0.01% 5137
2021
Q1
$47K Sell
714
-269
-27% -$17.7K ﹤0.01% 5630
2020
Q4
$33K Buy
983
+841
+592% +$28.2K ﹤0.01% 5559
2020
Q3
$8K Sell
142
-738
-84% -$41.6K ﹤0.01% 6174
2020
Q2
$33K Buy
880
+713
+427% +$26.7K ﹤0.01% 5364
2020
Q1
$4K Sell
167
-164
-50% -$3.93K ﹤0.01% 6504
2019
Q4
$17K Buy
331
+242
+272% +$12.4K ﹤0.01% 5939
2019
Q3
$5K Buy
89
+17
+24% +$955 ﹤0.01% 6533
2019
Q2
$7K Hold
72
﹤0.01% 6386
2019
Q1
$11K Hold
72
﹤0.01% 5931
2018
Q4
$11K Sell
72
-50
-41% -$7.64K ﹤0.01% 6276
2018
Q3
$30K Sell
122
-53
-30% -$13K ﹤0.01% 5645
2018
Q2
$39K Buy
175
+80
+84% +$17.8K ﹤0.01% 5293
2018
Q1
$23K Buy
95
+88
+1,257% +$21.3K ﹤0.01% 5450
2017
Q4
$2K Sell
7
-23
-77% -$6.57K ﹤0.01% 6661
2017
Q3
$11K Buy
30
+23
+329% +$8.43K ﹤0.01% 5930
2017
Q2
$2K Hold
7
﹤0.01% 6457
2017
Q1
$2K Sell
7
-11
-61% -$3.14K ﹤0.01% 6384
2016
Q4
$4K Buy
18
+11
+157% +$2.44K ﹤0.01% 6366
2016
Q3
$2K Hold
7
﹤0.01% 6486
2016
Q2
$1K Sell
7
-1
-13% -$143 ﹤0.01% 6656
2016
Q1
$3K Buy
+8
New +$3K ﹤0.01% 6345
2015
Q4
Sell
-12
Closed -$3K 7050
2015
Q3
$3K Sell
12
-36
-75% -$9K ﹤0.01% 6490
2015
Q2
$14K Buy
+48
New +$14K ﹤0.01% 5768